Luxottica, Essilor offer no merger concessions to EU regulators
[BRUSSELS] Luxottica and Essilor have not offered any concessions to allay EU antitrust regulators' concerns over their proposed 46 billion euro (S$74.29 billion) merger, increasing the possibility of a lengthy EU investigation into the deal.
Italian eyewear maker Luxottica, which owns brands such as Ray-Ban and Oakley, and French lens manufacturer Essilor had until Sept 19 to offer concessions after the EU competition enforcer expressed its reservations about the deal to the companies last week.
The European Commission recognises if the parties to a merger have made concessions. However, the filing on its website shows that Luxottica and Essilor had not done so.
Unless they managed to appease the Commission at last week's meeting, it is likely that the regulator will open a full-scale investigation lasting about four months following a preliminary review that ends on Sept 26.
Some companies prefer to offer concessions during this phase after getting a better idea of the regulator's concerns.
The deal, which will combine the world's largest maker of spectacles with the world's top lens-maker, Essilor, has triggered worries among retailers and competitors that the merged company may have too great a control of valuable brands and prescription lenses.
Both Luxottica and Essilor declined to comment on the EU enforcer's concerns.
US regulators are also examining the deal, which received the green light from New Zealand authorities earlier this month.
REUTERS
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO